Know Cancer

or
forgot password

    • cancer clinical trials in elyria, OH

    • Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
    Hematology Oncology Center Incorporated

    Trial Locations
    Hematology Oncology Center Incorporated
    Community Health Partners Regional Medical Center
    Adult Anaplastic Oligodendroglioma, Adult Mixed Glioma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Hematology Oncology Center

    Trial Locations
    Hematology Oncology Center
    Community Cancer Center
    Breast Cancer
    CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    Hematology Oncology Center Incorporated
    Elyria, Ohio 44035
    Recurrent Mantle Cell Lymphoma
    Octreotide in Treating Patients With Cancer-Related Malignant Ascites
    Hematology Oncology Center
    Elyria, Ohio 44035
    Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Hematology Oncology Center Incorporated

    Trial Locations
    Hematology Oncology Center Incorporated
    Community Health Partners Regional Medical Center
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance
    Hematology Oncology Center
    Elyria, Ohio 44035
    Breast Cancer, Cancer Survivor, Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Sexuality and Reproductive Issues, Spiritual Concerns
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Hematology Oncology Center Incorporated
    Elyria, Ohio 44035
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Anal Cancer
    Hematology Oncology Center

    Trial Locations
    Hematology Oncology Center
    Community Cancer Center
    Anal Cancer
    Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
    Hematology Oncology Center Incorporated
    Elyria, Ohio 44035
    Gastrointestinal Stromal Tumor
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Hematology Oncology Center Incorporated

    Trial Locations
    Hematology Oncology Center Incorporated
    Community Health Partners Regional Medical Center
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Community Health Partners Regional Medical Center
    Elyria, Ohio 44035
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
    Hematology Oncology Center

    Trial Locations
    Hematology Oncology Center
    Community Cancer Center
    Breast Cancer
    Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
    Hematology Oncology Center

    Trial Locations
    Hematology Oncology Center
    Community Cancer Center
    Small Intestine Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Hematology Oncology Center

    Trial Locations
    Hematology Oncology Center
    Community Cancer Center
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Hematology Oncology Center
    Elyria, Ohio 44035
    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Hematology Oncology Center Incorporated
    Elyria, Ohio 44035
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
    Hematology Oncology Center Incorporated
    Elyria, Ohio 44035
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Hematology Oncology Center Incorporated

    Trial Locations
    Hematology Oncology Center Incorporated
    Community Health Partners Regional Medical Center
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Hematology Oncology Center Incorporated

    Trial Locations
    Hematology Oncology Center Incorporated
    Community Health Partners Regional Medical Center
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Pemetrexed or Erlotinib as Second-Line Therapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Hematology Oncology Center Incorporated
    Elyria, Ohio 44035
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Hematology Oncology Center Incorporated

    Trial Locations
    Hematology Oncology Center Incorporated
    Community Health Partners Regional Medical Center
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
    Community Cancer Center
    Elyria, Ohio 44035
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    Acute Pain Caused by Paclitaxel in Patients With Cancer
    Hematology Oncology Center

    Trial Locations
    Hematology Oncology Center
    Community Cancer Center
    Chemotherapeutic Agent Toxicity, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific